Health Ministry to conduct 1 lakh tests per day with Indian kits by May

NEW DELHI: India will produce its rapid antibody testing kits independently and RTPCR diagnostic kits by May and the country would try to make possible to meet the target of one lakh tests per day by the end of May, health minister Harsh Vardhan said.
Vardhan said, “Out of at least half a dozen candidates supported for vaccines, four are in an advanced stage. Regulatory platform in one place has been constituted for speedy clearances.”

Vardhan addressed scientists of autonomous institutes and PSUs under the department of biotechnology before reviewing their work relating to Covid-19 solutions.
Scientists said, “at least nine of these studies were in early stages and one delivery and adjuvant system for improving immunogenicity of the candidate vaccine was at an advanced stage.”

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre